Why I Think Pfizer Is a Better Buy Than Merck & Co.

Pfizer's products and pipeline opportunity may give it an edge over Merck.



Pfizer (NYSE:PFE) and Merck & Co. (NYSE:MRK) are two of the biggest drugmakers on the planet, and both of these companies reward investors with a healthy dividend yield. But I believe it's Pfizer, not Merck, that ought to be in an investor's portfolio. 

Here's why...


Source: The Motley Fool


The 3 Best and Worst of Warren Buffet Stock Picks

Not every Berkshire holding is a winner - a few have been relative losers So Warren Buffet’s Berkshire Hathaway Inc. (NYSE: BRK.B)...